After years of delays and political wrangling, the federal government’s long-awaited hearing on whether to move marijuana from Schedule I to Schedule III of the Controlled Substances Act is finally underway.

CMS Medicare GLP-1 Bridge launches July 1, expanding access to weight-loss drugs for eligible patients while adding new provider, pharmacy, billing, and compliance requirements.

New AD/CVD petitions target choline salt imports from China. Learn key dates, potential duties, and what importers and supply chain companies should do now.